Chemist Warehouse and Sigma Healthcare kick off trading as $34bn merged entity
Chemist Warehouse co-founder Mario Verrocchi has urged franchisees to ‘stick around’ for five more years under the newly-minted merged firm as he plans for it be become the biggest thing in the country.
Business
Don't miss out on the headlines from Business. Followed categories will be added to My News.
The combined Sigma Healthcare/Chemist Warehouse group is only 40 years into a 100-year journey, Chemist Warehouse chief executive and co-founder Mario Verrocchi has told shareholders at the company’s $32bn relisting on the ASX.
“There’s still plenty to do,” he told a crowded room of more than 140 people, many of them veteran Chemist Warehouse staff and franchisees, after the ringing the bell ceremony for the combined company which is now the 22nd largest company on the ASX.
Unescrowed Sigma Healthcare shares owned by Chemist Warehouse shareholders hit the bourse on Thursday morning.
The 14-month journey to merge the two companies came to fruition on Thursday morning, creating a $32bn company which is vertically integrated across pharmaceuticals wholesale, distribution and consumer retail.
More than 15 million shares were traded early on Thursday, with the stock about 8 per cent higher at $2.98 at noon.
Mr Verrocchi said the success of Chemist Warehouse, which he co-founded with Jack Gance in 2000, was due to a “never give up attitude” and a belief that anything was possible.
“You can work away for forty years with minimal results and then, on the 41st or 44th year, you become the biggest thing in the country,” he said.
“The power of the grind and that never give up attitude is real. We are on a 100-year journey, and we are about 40 years into it.”
Mr Verrocchi, who will run all three pharmacy chains under the combined group of Chemist Warehouse, Amcal, and Discount Drug Stores.
The new company, with a combined turnover of $6.6bn, earnings before interest and tax of $605m and net profit of $522m, will be run by Sigma chief executive, Vikesh Ramsunder, with Mr Verrocchi overseeing the retail side of the business.
ASX: SIG Shares up
The company’s senior management and newly merged board will now be able to meet for the first time, having been legally constrained from getting together and talking strategy until now.
Mr Verrocchi joked that the last 14 months had been like agreeing to get married to someone but not being able to ask them where they lived or how much money they had in the bank.
“We couldn’t ask anything,” he said.
But he said it was now time for the two groups to “open up the suitcase” and start talking about the logistics of the merger.
He said he felt it would take five years to reap the benefits of the merger with Sigma.
“It’s going to take five years for the warehouses to be amalgamated, you have people to move around, you have rationalisation at every single level of the business.”
“I’ve chained myself to my desk for the next five years.”
The deal will bring together some of the strongest brands in the sector in Australia including Chemist Warehouse, My Chemist, Amcal, and Discount Drug.
The bulk of these are the 658 Chemist Warehouse stores, most of which are in Australia.
Mr Verrocchi also signalled a continued aggressive growth strategy for the group, which has a total of 880 outlets in Australia and around the world, which could see another 500 stores open in Australia.
He compared the potential of Chemist Warehouse to that of supermarket giants Coles and Woolworths which have some 900 to 1,000 outlets around the country.
“There is definitely organic growth in Australia and the opportunity to expand the range of products and wider distribution,” he said.
He said there were opportunities in the combined group to expand its existing brands as well as efficiencies to be had by combining the two groups.
Pharmacy expansion plans
Mr Verrocchi said the expanded stores in Australia would be a mix of all three group brands-depending on the location and market.
Chemist Warehouse shareholders own 85.7 per cent of the merged company with the rest held by Sigma shareholders.
Chemist Warehouse co-founder, Jack Gance, his brother Sam, and Mario Verrocchi will have a combined shareholding of 48 per cent of the newly listed company, the bulk of which cannot be sold until August 2026.
Mr Verrocchi, Jack Vance and his brother Sam, have a combined 49 per cent of the listed group, with restrictions on selling 90 per cent of their stock until August 2025.
He said there was a chance that some of Chemist Warehouse’s almost 300 franchisees could use the listing to sell down their shares, particularly to pay down debt, but urged them to ‘stick around’.
“They have all worked very hard and whatever rewards they get, they get,” he said.
“If they sell down their shares to pay off debt, I would be very happy.
“My personal view is stick around boys. We’ve got another five years to go, and I think we can do a really good job.”
He said there was also potential for the group, which has 50 stores in New Zealand, and others in China, Ireland and Dubai, to expand further offshore.
“The world’s about opportunities,” he said. “Success is at the intersection of opportunity and being ready.”
“We’re always ready, so if an opportunity comes, we’ll take it and see where it takes us.”
Investors on standby
Market attention will be on how much of the 37 per cent of other shares are sold by existing Chemist Warehouse shareholders, cashing in on the listing.
Meanwhile, David Di Pilla’s HMC Capital Group, which had owned more than five per cent of Sigma, announced on Wednesday that it had sold down some of its stake at prices of between $2.77 and $2.84 a share.
Investment banker Di Pilla was a key player in orchestrating the deal between the privately owned Chemist Warehouse and Sigma.
The deal followed Sigma’s earlier failed attempts to take over the API pharmacy group, the owners of Priceline pharmacies, in 2021, which was bought by Wesfarmers.
Some analysts have argued that the Sigma/ Chemist Warehouse deal leaves the company already fully priced, and it will need to boost its dividend payout if it is to attract significant interest from new retail shareholders.
The Chemist Warehouse group has pursued an aggressive growth strategy since it was formed in 2000.
The Chemist Warehouse group had 567 stores in Australia as of June 2024 with another 50 in New Zealand, 10 in China, and 10 in Ireland.
The company opened another 19 stores in the last six months of 2024, taking the total to 658.
The company’s chair, Michael Sammells, told investors in the prospectus that the merged group would “continue to pursue opportunities for growth in Australia and internationally.”
But the company will also be moving to rationalise significant costs from the merger.
Mr Sammells told shareholders that the group could deliver as much as $60m a year in synergies by the fourth year “through the rationalisation of duplicate costs and supply chain optimisation” across the combined business.
Chemist Warehouse co-founder Jack Gance will be a director of the combined company along with Mr Verrocchi and Mr Gance’s nephew, Damien Gance, the son of Jack’s younger brother Sam and Ms Danielle Di Pilla.
Damien Gance, a pharmacist, has been Chemist Warehouse’s long-time commercial director.
Originally published as Chemist Warehouse and Sigma Healthcare kick off trading as $34bn merged entity
Temple & Webster considers global push as profits rocket
Australia’s most popular online furniture store is weighing up the timing on taking its brand to the world and expanding overseas.
Political sting to Orora’s shrinking glass plant
The packaging play was Canberra’s great manufacturing hope, but making it in Australia is not so easy.